GlobalData's clinical trial report, "Precancerous Condition Global Clinical Trials Review, H1, 2012" provides data on the Precancerous Condition clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Precancerous Condition. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Precancerous Condition. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Precancerous Condition Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Precancerous Condition , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Precancerous Condition
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Precancerous Condition
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Applied Genetic Technologies Corporation
Clinical Trial Overview of Applied Genetic Technologies Corporation
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
British Columbia Cancer Agency
Clinical Trial Overview of British Columbia Cancer Agency
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
The University of Arizona
Clinical Trial Overview of The University of Arizona
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
Northwestern University
Clinical Trial Overview of Northwestern University
Vanderbilt-Ingram Cancer Center
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
University of California, Irvine
Clinical Trial Overview of University of California, Irvine
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
OHSU Knight Cancer Institute
Clinical Trial Overview of OHSU Knight Cancer Institute
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
University of Alabama at Birmingham
Clinical Trial Overview of University of Alabama at Birmingham
Fox Chase Cancer Center
Clinical Trial Overview of Fox Chase Cancer Center
University of Colorado
Clinical Trial Overview of University of Colorado
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables
Precancerous Condition Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Precancerous Condition Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Precancerous Condition Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Precancerous Condition Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
Precancerous Condition Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Precancerous Condition Therapeutics Clinical Trials, North America, Top Countries, 2012*
Precancerous Condition Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
Precancerous Condition Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Precancerous Condition Global Clinical Trials Review, H1, 2012 published by GlobalData in May 21, 2012. This report consists of Pages: 128 and the price starts from US $ 1000.
The contents of this page may be different from the latest version. Please contact us for details.
